We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 26.46%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+26.46%
3 Year Est. Return
+80.44%
5 Year Est. Return
+106.59%
10 Year Est. Return
+436.91%
AUM
$270M
AUM Growth
+$16M
Cap. Flow
+$2.67M
Cap. Flow %
0.99%
Top 10 Hldgs %
18.47%
Holding
276
New
10
Increased
19
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$427K
2
VZ icon
Verizon
VZ
+$325K
3
LLY icon
Eli Lilly
LLY
+$229K
4
EW icon
Edwards Lifesciences
EW
+$213K
5
CTXS
Citrix Systems Inc
CTXS
+$208K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$707K
2
FRX
FOREST LABORATORIES INC
FRX
+$420K
3
WFM
Whole Foods Market Inc
WFM
+$250K
4
NBR icon
Nabors Industries
NBR
+$247K
5
NVDA icon
NVIDIA
NVDA
+$211K

Sector Composition

Rank Sector Weight
1 Technology 16.94%
2 Financials 15.92%
3 Healthcare 14.21%
4 Communication Services 10.2%
5 Energy 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$5.01T
$10.4M 3.85%
446,460
– –
MSFT icon
2
Microsoft
MSFT
$2.92T
$6.11M 2.27%
146,532
– –
JNJ icon
3
Johnson & Johnson
JNJ
$646B
$6M 2.23%
57,339
– –
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.08T
$5.83M 2.16%
201,712
-202
-0.1% -$5.48K
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.78M 1.4%
29,897
– –
WFC icon
6
Wells Fargo
WFC
$257B
$3.72M 1.38%
70,819
+2,330
+3% +$117K
PG icon
7
Procter & Gamble
PG
$337B
$3.65M 1.35%
46,444
– –
KO icon
8
Coca-Cola
KO
$388B
$3.53M 1.31%
83,270
– –
COP icon
9
ConocoPhillips
COP
$144B
$3.42M 1.27%
39,895
+1,590
+4% +$124K
DIS icon
10
Walt Disney
DIS
$172B
$3.38M 1.25%
39,406
– –
IBM icon
11
IBM
IBM
$214B
$3.26M 1.21%
18,815
– –
JPM icon
12
JPMorgan Chase
JPM
$925B
$3.22M 1.19%
55,892
– –
VZ icon
13
Verizon
VZ
$201B
$3.15M 1.17%
64,383
+6,710
+12% +$325K
MRK icon
14
Merck
MRK
$325B
$3.11M 1.15%
56,388
+2,096
+4% +$114K
T icon
15
AT&T
T
$168B
$3.05M 1.13%
114,285
– –
PEP icon
16
PepsiCo
PEP
$198B
$2.98M 1.11%
33,412
– –
CMCSA icon
17
Comcast
CMCSA
$87.7B
$2.86M 1.06%
106,546
– –
INTC icon
18
Intel
INTC
$416B
$2.76M 1.02%
89,215
– –
ORCL icon
19
Oracle
ORCL
$336B
$2.73M 1.01%
67,428
– –
MMM icon
20
3M
MMM
$92.6B
$2.6M 0.96%
21,703
– –
GILD icon
21
Gilead Sciences
GILD
$166B
$2.59M 0.96%
31,272
– –
SLB icon
22
SLB Ltd
SLB
$73.2B
$2.59M 0.96%
21,941
– –
QCOM icon
23
Qualcomm
QCOM
$168B
$2.58M 0.96%
32,565
– –
BAC icon
24
Bank of America
BAC
$431B
$2.35M 0.87%
153,220
– –
C icon
25
Citigroup
C
$215B
$2.33M 0.86%
49,433
+2,490
+5% +$118K
1
2 3 4 5

Similar funds

LIA
LBMC Investment Advisors Brentwood, Tennessee $1.64B AUM 15.26% 1-Year Est. Return
GA
Greenspring Advisors Towson, Maryland $1.64B AUM
AHC
Adell Harriman & Carpenter Houston, Texas $1.64B AUM 36.77% 1-Year Est. Return
UMC
UNC Management Company Chapel Hill, North Carolina $1.64B AUM 17.65% 1-Year Est. Return
1SP
140 Summer Partners New York $1.64B AUM 47.44% 1-Year Est. Return
MRG
Milestone Resources Group Road Town Tortola, British Virgin Islands $1.64B AUM 7.52% 1-Year Est. Return
TIAA Trust, National Association
TIAA Trust, National Association Charlotte, North Carolina $1.65B AUM 16.63% 1-Year Est. Return
TCA
Troluce Capital Advisors Dorado, Puerto Rico $1.63B AUM 37.23% 1-Year Est. Return

Everence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Everence Capital Management held 276 positions worth $270M, up 6.3% from $254M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Everence Capital Management's Q2 2014 filing shows 10 new, 19 increased, 6 reduced and 5 closed positions. Its largest new stake was Edwards Lifesciences: 15,720 shares worth $225K. The largest sale was Celgene Corp, an estimated $707K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Everence Capital Management's largest Q2 2014 buy was Edwards Lifesciences: 15,720 shares worth $225K.
  • Everence Capital Management added most to General Motors in Q2 2014, an estimated $427K increase.
  • Everence Capital Management's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $707K.
  • Everence Capital Management fully exited FOREST LABORATORIES INC in Q2 2014, selling an estimated $420K.
  • Everence Capital Management's ten largest holdings make up 18% of its $270M portfolio in Q2 2014.
  • Everence Capital Management opened 10 new positions and closed 5 in Q2 2014.
  • Everence Capital Management's portfolio value rose 6.3% quarter-over-quarter to $270M.

Based on Everence Capital Management's 13F filing for Q2 2014, filed 4 Aug 2014.